Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Sep 01, 2015 Theratechnologies Announces Commercialization Agreement for Tesamorelin in South Korea Aug 06, 2015 Theratechnologies Closes its Offering of Units Jul 31, 2015 Theratechnologies Announces the Exercise of the Over-Allotment Option Jul 30, 2015 Theratechnologies Announces The Filing of a Final Short Form Prospectus (ccn) Jul 24, 2015 Theratechnologies Announces $9,600,000 Firm Offering of Units and Filing of Preliminary Short Form Prospectus Jul 14, 2015 EGRIFTA™ (Tesamorelin for Injection) Approved in Mexico Jul 14, 2015 Theratechnologies Announces Financial Results for Second Quarter of 2015 Jun 25, 2015 Theratechnologies Initiates Canadian Distribution of EGRIFTA™ (Tesamorelin for Injection) Jun 09, 2015 Tesamorelin to be Assessed in the Treatment of Liver Disease in HIV-Infected Patients May 20, 2015 Announcements in Conjunction With Theratechnologies Annual Meeting First page « Previous page ‹ … Page 29 Page 30 Page 31 Page 32 Current page 33 Page 34 Page 35 Page 36 Page 37 … Next page › Last page » Displaying 321 - 330 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Jul 24, 2015 Theratechnologies Announces $9,600,000 Firm Offering of Units and Filing of Preliminary Short Form Prospectus
Jun 25, 2015 Theratechnologies Initiates Canadian Distribution of EGRIFTA™ (Tesamorelin for Injection)
